Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This reflects a new version of the page without altering its substantive content.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:29.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page's release/version metadata without changing the study content.
    Difference
    0.1%
    Check dated 2026-08-11T13:30:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page footer now lists a revision update from v3.6.3 to v3.6.4, indicating a new edition of the page. No substantive study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2026-07-28T05:28:00.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new internal release for the study page. This update does not modify the study details or eligibility criteria presented on the page.
    Difference
    0.1%
    Check dated 2026-07-06T18:18:05.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page system.
    Difference
    0.1%
    Check dated 2026-06-29T15:51:48.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', and new help sections were added to guide users on reading the study record and joining a study. These changes provide clearer pathways for potential participants and improve navigation on the page.
    Difference
    0.4%
    Check dated 2026-06-15T08:27:27.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.